EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis
| Autor: | Tsai, Jeng-Shiuan, Su, Po-Lan, Yang, Szu-Chun, Chang, Chao-Chun, Lin, Chia-Ying, Yen, Yi-Ting, Tseng, Yau-Lin, Lai, Wu-Wei, Lin, Chien-Chung, Su, Wu-Chou |
|---|---|
| Zdroj: | In Journal of the Formosan Medical Association September 2021 120(9):1729-1739 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|